All Stories

  1. Plasma next generation sequencing and droplet digital PCR‐based detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced lung cancer treated with subsequent‐line osimertinib

    Article • Thoracic Cancer, August 2019, Wiley

    Dr Therese M Becker

  2. The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: A prospective study

    Article • Lung Cancer, August 2019, Elsevier

    Dr Therese M Becker

  3. Expression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinoma

    Article • Pathology, August 2019, Elsevier

    Dr Therese M Becker

  4. Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes

    Article • Cells, July 2019, MDPI AG

    Dr Therese M Becker

  5. Immunomagnetic isolation of circulating melanoma cells and detection of PD-L1 status

    Article • PLoS ONE, February 2019, PLOS

    Dr Therese M Becker

  6. Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer

    Article • World Journal of Gastroenterology, February 2018, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Therese M Becker

  7. Droplet Digital PCR Based Detection of EGFR Mutations in Advanced Lung Cancer Patient Liquid Biopsies: A Comparison of Circulating Tumour DNA Extraction Kits

    Article • Journal of Molecular Biomarkers & Diagnosis, January 2018, OMICS Publishing Group

    Dr Therese M Becker

  8. Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin

    Article • Journal of Circulating Biomarkers, January 2018, SAGE Publications

    Dr Therese M Becker

  9. Clinical outcomes in patients with advanced epidermal growth factor receptor-mutated non-small-cell lung cancer in South Western Sydney Local Health District

    Article • Internal Medicine Journal, December 2017, Wiley

    Dr Therese M Becker

  10. CTC-mRNA (AR-V7) Analysis from Blood Samples—Impact of Blood Collection Tube and Storage Time

    Article • International Journal of Molecular Sciences, May 2017, MDPI AG

    Dr Therese M Becker

  11. Circulating pancreatic stellate (stromal) cells in pancreatic cancer—a fertile area for novel research

    Article • Carcinogenesis, April 2017, Oxford University Press (OUP)

    Dr Therese M Becker

  12. The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis

    Article • Oncotarget, February 2017, Impact Journals, LLC

    Dr Therese M Becker

  13. Importance and Detection of Epithelial-to-Mesenchymal Transition (EMT) Phenotype in CTCs

    Article • September 2016, IntechOpen

    Dr Therese M Becker

  14. Droplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood Biopsies

    Article • International Journal of Molecular Sciences, August 2016, MDPI AG

    Dr Therese M Becker

  15. Gastric cancer stem cells: evidence, potential markers, and clinical implications

    Article • Journal of Gastroenterology, October 2015, Springer Science + Business Media

    Dr Therese M Becker

  16. Predictive and prognostic value of circulating tumor cell detection in lung cancer: A clinician's perspective

    Article • Critical Reviews in Oncology/Hematology, February 2015, Elsevier

    Dr Therese M Becker

  17. Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer

    Article • Journal of Clinical Pathology, July 2014, BMJ

    Dr Therese M Becker

  18. Circulating tumour cells—a bona fide cause of metastatic cancer

    Article • Cancer and Metastasis Reviews, May 2014, Springer Science + Business Media

    Dr Therese M Becker

  19. Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer

    Article • Cancer Letters, April 2014, Elsevier

    Dr Therese M Becker

  20. BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact

    Article • Clinical Cancer Research, January 2014, American Association for Cancer Research (AACR)

    Dr Therese M Becker

  21. New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use

    Article • International Journal of Cancer, October 2013, Wiley

    Dr Therese M Becker

  22. Acquired Resistance to BRAF Inhibition Can Confer Cross-Resistance to Combined BRAF/MEK Inhibition

    Article • Journal of Investigative Dermatology, October 2013, Elsevier

    Dr Therese M Becker

  23. Vemurafenib Induces Senescence Features in Melanoma Cells

    Article • Journal of Investigative Dermatology, June 2013, Elsevier

    Dr Therese M Becker

  24. Secondary c-Kit mutations confer acquired resistance to RTK inhibitors in c-Kit mutant melanoma cells

    Article • Pigment Cell & Melanoma Research, May 2013, Wiley

    Dr Therese M Becker

  25. Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma

    Article • Molecular Cancer Therapeutics, May 2013, American Association for Cancer Research (AACR)

    Dr Therese M Becker

  26. Oncogenic B-RAFV600E Signaling Induces the T-Box3 Transcriptional Repressor to Repress E-Cadherin and Enhance Melanoma Cell Invasion

    Article • Journal of Investigative Dermatology, May 2013, Elsevier

    Dr Therese M Becker

  27. Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor

    Article • Oncogene, March 2013, Springer Science + Business Media

    Dr Therese M Becker

  28. Molecular Mechanisms of Cellular Senescence

    Article • February 2013, IntechOpen

    Dr Therese M Becker

  29. The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma

    Article • Oncogene, December 2012, Springer Science + Business Media

    Dr Therese M Becker

  30. Absence of Distinguishing Senescence Traits in Human Melanocytic Nevi

    Article • Journal of Investigative Dermatology, September 2012, Elsevier

    Dr Therese M Becker

  31. Acquired Resistance to BRAF Inhibition Can Confer Cross-Resistance to Combined BRAF/MEK Inhibition

    Article • Journal of Investigative Dermatology, July 2012, Elsevier

    Dr Therese M Becker

  32. Chromatin Remodeling in Carcinoma Cells

    Article • May 2012, Wiley

    Dr Therese M Becker

  33. Selective Loss of Wild-Type p16INK4a Expression in Human Nevi

    Article • Journal of Investigative Dermatology, November 2011, Elsevier

    Dr Therese M Becker

  34. Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS

    Article • Cell Death and Disease, September 2010, Springer Science + Business Media

    Dr Therese M Becker

  35. Oncogenic B-RAFV600E Promotes Anchorage-Independent Survival of Human Melanocytes

    Article • Journal of Investigative Dermatology, August 2010, Elsevier

    Dr Therese M Becker

  36. IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence

    Article • Cell, May 2010, Elsevier

    Dr Therese M Becker

  37. Abstract 1790: Apoptotic response of mutant B-RAF human melanoma cells to a B-RAF inhibitor involves increased splicing production of BimS

    Article • Cancer Research, April 2010, American Association for Cancer Research (AACR)

    Dr Therese M Becker

  38. Predicting functional significance of cancer-associated p16INK4a mutations in CDKN2A

    Article • Human Mutation, March 2010, Wiley

    Dr Therese M Becker

  39. Amino terminal hydrophobic import signals target the p14ARF tumor suppressor to the mitochondria

    Article • Cell Cycle, February 2010, Taylor & Francis

    Dr Therese M Becker

  40. Oncogene-Induced Senescence Does Not Require the p16INK4a or p14ARF Melanoma Tumor Suppressors

    Article • Journal of Investigative Dermatology, August 2009, Elsevier

    Dr Therese M Becker

  41. The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence

    Article • Aging, May 2009, Impact Journals, LLC

    Dr Therese M Becker

  42. Wild type and melanoma-associated mutant p16INK4aproteins do not oligomerize in vivo

    Article • Pigment Cell & Melanoma Research, February 2009, Wiley

    Dr Therese M Becker

  43. The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a

    Article • Molecular Cancer, January 2009, Springer Science + Business Media

    Dr Therese M Becker

  44. p16INK4a-induced senescence is disabled by melanoma-associated mutations

    Article • Aging Cell, October 2008, Wiley

    Dr Therese M Becker

  45. Physical and Functional Interaction of the p14ARF Tumor Suppressor with Ribosomes

    Article • Journal of Biological Chemistry, October 2006, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Therese M Becker

  46. Impaired inhibition of NF-κB activity by melanoma-associated p16INK4a mutations

    Article • Biochemical and Biophysical Research Communications, July 2005, Elsevier

    Dr Therese M Becker

  47. The melanoma-associated 24 base pair duplication in p16INK4a is functionally impaired

    Article • International Journal of Cancer, January 2005, Wiley

    Dr Therese M Becker

  48. Cell cycle regulation in the melanocyte

    Article • September 2003, Taylor & Francis

    Dr Therese M Becker

  49. Regulation of Cellular Senescence by the Retinoblastoma Pathway

    Article • January 2003, Springer Science + Business Media

    Dr Therese M Becker

  50. eMelanoBase: An online locus-specific variant database for familial melanoma

    Article • Human Mutation, December 2002, Wiley

    Dr Therese M Becker

  51. Association of p14ARF with the p120E4FTranscriptional Repressor Enhances Cell Cycle Inhibition

    Article • Journal of Biological Chemistry, November 2002, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Therese M Becker

  52. Differential expression of p16INK4a and p16β transcripts in B-lymphoblastoid cells from members of hereditary melanoma families without CDKN2A exon mutations

    Article • Oncogene, July 1997, Springer Science + Business Media

    Dr Therese M Becker

  53. Differential expression of p16INK4A and p16b transcripts in hereditary melanoma families

    Article • Melanoma Research, June 1997, Wolters Kluwer Health

    Dr Therese M Becker